These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1952 related items for PubMed ID: 22161738

  • 1. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L, Meng X, Hochfeld M, Stahl SM.
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [Abstract] [Full Text] [Related]

  • 2. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    Cutler AJ, Kalali AH, Weiden PJ, Hamilton J, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.
    Potkin SG, Litman RE, Torres R, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S4-11. PubMed ID: 18334911
    [Abstract] [Full Text] [Related]

  • 4. Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
    Weiden PJ, Cutler AJ, Polymeropoulos MH, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S12-9. PubMed ID: 18334908
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM, Lauriello J, Laska E, Di Marino M, Wolfgang CD.
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [Abstract] [Full Text] [Related]

  • 6. Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic.
    Citrome L.
    Int J Clin Pract; 2009 Aug; 63(8):1237-48. PubMed ID: 19624791
    [Abstract] [Full Text] [Related]

  • 7. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S.
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [Abstract] [Full Text] [Related]

  • 8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 9. Iloperidone for the treatment of schizophrenia.
    Marino J, Caballero J.
    Ann Pharmacother; 2010 May; 44(5):863-70. PubMed ID: 20388862
    [Abstract] [Full Text] [Related]

  • 10. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.
    Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W.
    J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis.
    Citrome L, Meng X, Hochfeld M.
    Schizophr Res; 2011 Sep; 131(1-3):75-81. PubMed ID: 21700430
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    Addington DE, Pantelis C, Dineen M, Benattia I, Romano SJ.
    J Clin Psychiatry; 2004 Dec; 65(12):1624-33. PubMed ID: 15641867
    [Abstract] [Full Text] [Related]

  • 13. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 14. Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial.
    Cutler AJ, Kalali AH, Mattingly GW, Kunovac J, Meng X.
    CNS Spectr; 2013 Feb; 18(1):43-54. PubMed ID: 23312567
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    Zhao T, Park TW, Yang JC, Huang GB, Kim MG, Lee KH, Chung YC.
    Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
    [Abstract] [Full Text] [Related]

  • 16. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL, Burns T, Morosini P, Gagnon DD, Rothman M, Adriaenssen I.
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [Abstract] [Full Text] [Related]

  • 17. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Miceli JJ, Tensfeldt TG, Shiovitz T, Anziano RJ, O'Gorman C, Harrigan RH.
    Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
    [Abstract] [Full Text] [Related]

  • 18. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG, Saha AR, Kujawa MJ, Carson WH, Ali M, Stock E, Stringfellow J, Ingenito G, Marder SR.
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [Abstract] [Full Text] [Related]

  • 19. Paliperidone extended-release tablets in patients with recently diagnosed schizophrenia.
    Canuso CM, Bossie CA, Amatniek J, Turkoz I, Pandina G, Cornblatt B.
    Early Interv Psychiatry; 2010 Feb; 4(1):64-78. PubMed ID: 20199482
    [Abstract] [Full Text] [Related]

  • 20. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
    Nasrallah HA, Silva R, Phillips D, Cucchiaro J, Hsu J, Xu J, Loebel A.
    J Psychiatr Res; 2013 May; 47(5):670-7. PubMed ID: 23421963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 98.